WHO ICTRP trial

A Double-Blind, Randomized Controlled Study of Dexmedetomidine Hydrochloride…

ChiCTR2600117586 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2600117586
Public title A Double-Blind, Randomized Controlled Study of Dexmedetomidine Hydrochloride Nasal Spray for Sedation during Thoracic Closed Drainage Procedure
Scientific title A Double-Blind, Randomized Controlled Study of Dexmedetomidine Hydrochloride Nasal Spray for Sedation during Thoracic Closed Drainage Procedure
Primary sponsor The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Patients scheduled for closed thoracostomy, including but not limited to those undergoing pleural effusion drainage or diagnostic thoracentesis
Interventions Placebo group:Placebo nasal spray (same volume, 4 sprays), administered intranasally 20 minutes before local anesthesia.;Intervention group:Dexmedetomidine Hydrochloride Nasal Spray, 100 µg (4 sprays), administered intranasally 20 minutes…
Registration date Jan 26, 2026
Target size Placebo group:40;Intervention group:40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations